1. The distribution of angiotensinogen and endogenous renin-like activity were analysed in different areas of the central nervous system in normal and DOC-salt-treated hypertensive rats.
Introduction
The presence and physiological role of an endogenous renin-angiotensin system in the brain has been the subject of considerable debate in the past few years 11-81. Recently, renin has been immunochemically identified in the brain of man (91 and the rat [ 10, 111. In a previous report 1121 we have also shown the presence of a renin-like enzyme active at the physiological pH in different areas of the central nervous system of the rat. Moreover, we have observed an increment in the endogenous renin-lie activity in some regions of the central nervous system during the development of DOC-salt hypertension in the rat. This change in angiotensin I (ANG I) formation was not related to an increased concentration of the enzyme, suggesting that endogenous brain angiotensinogen could be the limiting factor in the activity of the enzymatic system.
Based on these findings the present work was undertaken to analyse simultaneously the distribution of angiotensinogen concentration and of the endogenous activity of the renin-like system in the central nervous system of control and DOC-salt-treated rats 4 weeks' after the initiation of the treatment.
Methods
Male rats of the Wistar strain in the weight range 2 W 3 0 0 g were used. Twenty-four rats without any manipulation were used as control and 35 were used as experimental animals. Rats were kept, treated, killed and processed and tissues were extracted and prepared as described in a previous report 1121.
Angiotensinogen concentration and renin-like activity (RA) were evaluated in the supernatant of central nervous system tissue homogenates as follows: (b) RA: a portion (50 p1) of each supernatant was incubated under the conditions of (a) without the addition of renin. Incubations were conducted with continuous shaking at 37OC during 1 h for angiotensinogen and during 3 h for RA. Enzymatic reaction was stopped by freezing the samples at -2OOC. Samples were kept frozen until assay. ANG I present in all the samples was evaluated by radioimmunoassay (RIA) (BectonDickinson). Plasma angiotensinogen concentration was determined by incubating 5 p1 of a 1/10 dilution of each sample in the presence of 0.01 G U of purified hog renin during 1 h in similar conditions to PRA [131. ANG I formed was evaluated by radioimmunoassay.
The amount of blood remaining in the central nervous system even after thorough rinsing with 20 ml of sodium chloride solution (154 mmol/l: saline) was determined in five intact rats. The animals were anaesthetized with sodium pentobarbital (35 mg/kg). To allow adequate equilibration '"I-labelled serum albumin was given intravenously 20 min before they were killed. A blood sample was obtained immediately before killing and processing the animals as described before [ 121. Blood and tissue samples were placed in weighed glass tubes, reweighed and radioactivity was determined in a well-type gamma counter.
Data are expressed as means f SEM. significance of differences was calculated by the Student's t-test.
Results

Blood pressure and plasma angiotensinogen concentration
The DOC-salt treated animals increased their blood pressure from the first week of treatment; increments were significant during the second week (+24%; P < 0.001) and continued to increase until the end of the experiment (+37%; P < 0.0005). Angiotensinogen decreased significantly after the second week of the experimental period (control: 834.62 f 79.66 ng of ANG I/ml; 13 days of treatment: 629.96 f 4 1.14 ng of ANG Vml; P < 0.02). The difference from control animals was even more significant at the end of the experiment (control: 1054.47 & 77-25 ng of ANG Vml; DOC-salt: 604.29 f 47.23 ng of ANG I/ml; P < 04005).
Angiotensinogen concentration, endogenous renin-like activity and blood content in the central nervous system
The results are presented in Table 1 . DOC-salt treatment produced a significant increase in angiotensinogen and RA in the cerebral cortex. cerebellum, hypothalamus and brain stem, but no significant changes were observed in the remaining regions; higher blood content was detected in these regions than in the former parts.
Discussion
Present results confirm our previous report on the endogenous formation of ANG I when homogenates of brain tissue were incubated at physiological pH (121. These data support the wide Increased RA in cerebral cortex, cerebellum, hypothalamus and brain stem of DOC-salttreated rats has also been confirmed. The increments seem to be mainly due to an increase in angiotensinogen, induced by the experimental treatment. According to one report t171 some brain regions respond to adrenalectomy with a decreased angiotensinogen, and corticosterone replacement therapy reversed this effect. Mineralocorticoids might have a similar effect; thus they could be involved in central angiotensinogen regulation. Alternatively DOC may have glucocorticoid activity.
The degree of blood contamination was small (1-3%), but, owing to the high plasma angiotensinogen, large enough to alter the concentration of the prohormone in the central nervous system. On the other hand, blood contamination was unequally distributed in the different areas. Since DOC-salt treatment produced a significant decrease in plasma angiotensinogen, blood contamination could only diminish the real magnitude of the increment in central angiotensinogen and, even more, could conceal changes in some of the studied areas. We think that angiotensinogen was increased all over the central nervous system of the DOC-salt-treated rats but, owing to blood contamination, the changes in some areas proved to be undetectable.
Morris & Reid I1 81 have postulated that most of the angiotensinogen in the brain is of cerebrospinal fluid origin and is present in the extracellular space. Supporting this possibility, preliminary data obtained in our laboratory indicate a significant increase in cerebrospinal fluid angiotensinogen in DOC-salt-treated rats. Nevertheless, the significant differences in angiotensinogen observed among the analysed areas could hardly be explained by the diverse magnitude of the extracellular space in these regions.
In conclusion, present data indicate that saturating levels of angiotensinogen are not attained in the brain; therefore angiotensinogen may be a rate-limiting and regulatory factor in production of ANG I [191. Increased brain angiotensinogen in DOC-salt hypertensive rats might be involved in the pathogenesis of this type of hypertension, since ANG I1 liberated in the region of the cerebral ventricles, through its central pressor and vasopressin-releasing effects [20l, may play some role in sustaining high blood pressure.
